Core decision variable
Exudate level
Determines dressing type more than any other factor
Most confused pair
Foam vs Hydrocolloid
Different mechanisms — not interchangeable
Longest wear time
7 days
Hydrocolloid (low exudate wounds)
Highest absorbency
Foam Dressing
Moderate to heavy exudate wounds
Why this comparison matters

The problem with dressing substitution in B2B procurement

Foam, hydrocolloid, transparent PU film, and island dressings collectively account for the majority of advanced wound dressing procurement volume in hospital and distributor supply chains. They are also the four types most frequently substituted for each other when a preferred product is unavailable — often without understanding the clinical and compliance consequences.

A literature review of 11 randomized controlled trials found that when used on exuding wounds, foam dressings consistently outperformed hydrocolloids in exudate management, conformability, and ease of use. Yet procurement decisions routinely treat them as equivalent alternatives. In regulated markets, substituting one type for another can trigger contract non-compliance, failed audits, and costly returns.

"Choosing the proper wound dressing is crucial to accelerate healing, reduce treatment costs, and improve the patient's overall well-being."

StatPearls, National Library of Medicine — Wound Dressings (2026 edition)
Section 01

The four dressing types: detailed profiles

Each operates on a distinct mechanism. Understanding that mechanism is the foundation for correct procurement specification.

Type 01
Foam Dressing
High-capacity exudate management with cushioning and thermal insulation
MaterialPolyurethane foam, open-cell structure. Hydrophobic outer layer, semi-permeable to vapour.
MechanismOpen cells pull fluid by capillary action; retained in foam matrix. Does not form gel.
AbsorbencyModerate–very high. EN 13726 capacity typically 5–20 g/10cm².
Wear time1–4 days. Change when saturated.
Secondary neededNo (adhesive bordered). Yes (non-adhesive).
Pressure ulcersHeavy exudateDry wounds — avoid
Type 02
Hydrocolloid
Moist healing, autolytic debridement, extended wear for low-exudate wounds
MaterialGel-forming agents (CMC, gelatin, pectin) in adhesive compound on PU film backing.
MechanismAbsorbs fluid, forms gel. Occlusive — seals against bacteria and oxygen.
AbsorbencyLow–moderate. Scant to moderate exudate only. Heavy exudate → gel failure risk.
Wear time3–7 days. Longest of the four types.
Secondary neededNo. Self-adhesive system.
Autolytic debridementChronic ulcersInfected — contraindicated
Type 03
Transparent PU Film
Wound visibility, IV site protection — for minimal exudate only
MaterialThin PU film (25–50μm) with pressure-sensitive acrylic adhesive.
MechanismTransparent waterproof barrier. Semi-permeable: allows vapour/O₂, blocks liquid water and bacteria.
AbsorbencyNone. Minimal exudate only. Any exudate = maceration risk.
Wear timeUp to 7 days (IV sites). Change immediately if fluid accumulates.
Secondary neededNo. Also used as secondary dressing over alginates/foam.
IV/catheter sitesWound visibilityAny exudate — never use
Type 04
Island / Border Dressing
Ready-to-use post-op protection — pad plus adhesive border in one product
MaterialCentral absorbent pad (non-woven or foam core) surrounded by adhesive PU or non-woven border.
MechanismPad manages exudate; border secures without separate tape. Combined pad-and-film system.
AbsorbencyLow–moderate. Non-woven core: low. Foam core: moderate. Not for heavy exudate.
Wear time1–3 days. Change when pad saturated or border fails.
Secondary neededNo. Self-contained single-product application.
Post-surgicalLow–moderate exudateHeavy exudate — avoid
Section 02

Full comparison: 12 parameters

ParameterFoamHydrocolloidTransparent PUIsland
AbsorbencyModerate–Very HighLow–ModerateNoneLow–Moderate
Exudate levelModerate–HeavyScant–ModerateNone–MinimalLow–Moderate
Wound visibilityNoNoYesNo
Self-adhesiveSomeYesYesYes
Secondary dressingSometimesNoNoNo
Wear time1–4 days3–7 daysUp to 7 days1–3 days
Moist wound healingYesYesPartialPartial
Autolytic debridementPartialYesNoNo
WaterproofSomeYesYesSome
Suitable infected woundsWith careNoNoWith care
EU MDR classClass IIaClass IIaClass I/IIaClass IIa
Relative unit costMedium–HighMediumLow–MediumLow–Medium
Section 03

When to use each dressing type

Use foam dressing when:

  • The wound produces moderate to heavy exudate — foam's open-cell structure has the highest fluid retention capacity of the four types
  • Pressure injury prevention or management is required — foam reduces vertical pressure, shear, and friction on peri-wound tissue
  • Peri-wound skin is fragile — specify silicone-bordered foam to prevent trauma at dressing change

Use hydrocolloid when:

  • Low to moderate exudate and autolytic debridement is required — moist gel environment softens necrotic tissue without sharp debridement
  • Minimizing dressing change frequency is a priority — 3–7 day wear time reduces nursing time and cost per care episode
Hydrocolloid contraindications — do not use when:

Wounds with heavy exudate, clinically infected wounds, full-thickness burns, wounds with deep tunnels, or any wound requiring frequent visual inspection. Use foam or transparent PU film instead.

Use transparent PU film when:

  • IV catheter or central line site protection is required — transparent film is the clinical standard, allowing site visualization without removal
  • Post-operative protection for closed, sutured wounds with minimal drainage
Critical error: transparent film on exuding wounds

PU film has zero absorbency. Any exudate accumulates under the film causing maceration and accelerated bacterial growth. This is one of the most consequential incorrect substitutions in wound care procurement.

Use island dressing when:

  • Post-surgical protection where speed of application is a priority — eliminates need for separate tape or secondary dressing
  • High-volume procurement where application standardization across non-specialist staff is required
Section 04

Acceptable substitutions — and what to avoid

Supply disruptions regularly force procurement teams to make substitution decisions. The following rules define which substitutions are clinically acceptable and which carry significant risk.

Hydrocolloid
Low exudate wound
→
Thin silicone foam
✓ Acceptable
Thin silicone foam is clinically acceptable on low-exudate wounds. Wear time will be shorter. Do not use non-adhesive foam — requires secondary dressing.
Island Dressing
Post-operative
→
Bordered foam
✓ Acceptable
Adhesive bordered foam provides comparable protection with higher absorbency. Appropriate if drainage is higher than expected.
Foam — heavy exudate
→
Hydrocolloid
✗ Never acceptable
Hydrocolloid gel fails under heavy exudate — leakage, maceration, and increased infection risk. Never substitute on moderate-to-heavy exuding wounds.
Any absorbent dressing
→
Transparent PU Film
✗ Never acceptable
Zero absorbency — any exudate causes maceration and infection risk. No clinical scenario makes this substitution acceptable on an exuding wound.
Section 05

Unit cost benchmarks: China OEM sourcing

Typical FOB China unit costs at moderate B2B volumes (10,000–50,000 units per SKU) from ISO 13485-certified manufacturers. Prices vary by size, format, contact layer material, and private label requirements.

Reference size
10×10cm
Standard comparison
Foam Dressing
$0.35–$0.85
Per unit FOB China
Hydrocolloid
$0.25–$0.65
Per unit FOB China
Transparent PU Film
$0.08–$0.25
Per unit FOB China
Model total cost of care, not unit cost

A hydrocolloid at $0.50/unit with 5-day wear delivers lower total cost than foam at $0.40/unit requiring daily changes. Always model: unit cost × average dressing changes over expected healing period.

Section 06

Purchase order specification requirements

  • Product type explicit: e.g. "Adhesive silicone-bordered polyurethane foam dressing" — not just "foam dressing"
  • Dimensions in cm and thickness (foam). Contact layer: standard PU or silicone — must specify
  • Sterility: EO or Gamma, SAL 10⁻⁶, sterilization date on label required
  • Shelf life minimum: 3 years from sterilization date
  • CE certificate: must reference EU MDR 2017/745 with valid Notified Body number
  • ISO 10993 biocompatibility test report required for all wound contact materials
  • EN 13726 absorption data required for foam and hydrocolloid dressings
  • Labeling language: English, Arabic, or bilingual — specify for GCC market orders

Sourcing foam, hydrocolloid or island dressings?

Kingphar manufactures all four dressing types with CE certification, ISO 10993 documentation, and full OEM support for GCC, European, and North American markets.

Request a Quote Back to Buyer's Guide
A
Albar
Content Auditor & Content Operations · Kingphar Medical
LinkedIn Profile More Articles